JP2021531757A5 - - Google Patents

Info

Publication number
JP2021531757A5
JP2021531757A5 JP2021500916A JP2021500916A JP2021531757A5 JP 2021531757 A5 JP2021531757 A5 JP 2021531757A5 JP 2021500916 A JP2021500916 A JP 2021500916A JP 2021500916 A JP2021500916 A JP 2021500916A JP 2021531757 A5 JP2021531757 A5 JP 2021531757A5
Authority
JP
Japan
Prior art keywords
domain
polypeptide
monomer
igg1
domain monomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021500916A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021531757A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/041492 external-priority patent/WO2020014545A1/en
Publication of JP2021531757A publication Critical patent/JP2021531757A/ja
Publication of JP2021531757A5 publication Critical patent/JP2021531757A5/ja
Withdrawn legal-status Critical Current

Links

JP2021500916A 2018-07-11 2019-07-11 改変されたFc−抗原結合ドメイン構築体に関する組成物および方法 Withdrawn JP2021531757A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862696708P 2018-07-11 2018-07-11
US62/696,708 2018-07-11
PCT/US2019/041492 WO2020014545A1 (en) 2018-07-11 2019-07-11 Compositions and methods related to engineered fc-antigen binding domain constructs

Publications (2)

Publication Number Publication Date
JP2021531757A JP2021531757A (ja) 2021-11-25
JP2021531757A5 true JP2021531757A5 (https=) 2022-07-14

Family

ID=69141749

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021500916A Withdrawn JP2021531757A (ja) 2018-07-11 2019-07-11 改変されたFc−抗原結合ドメイン構築体に関する組成物および方法

Country Status (11)

Country Link
US (1) US20210238310A1 (https=)
EP (1) EP3820523A4 (https=)
JP (1) JP2021531757A (https=)
KR (1) KR20210043583A (https=)
CN (1) CN113164592A (https=)
AU (1) AU2019300020A1 (https=)
BR (1) BR112021000388A2 (https=)
CA (1) CA3106256A1 (https=)
IL (1) IL279999A (https=)
MX (1) MX2021000288A (https=)
WO (1) WO2020014545A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202005879D0 (en) * 2020-04-22 2020-06-03 Petmedix Ltd Heterodimeric proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1220465A1 (zh) * 2013-03-06 2017-05-05 Merrimack Pharmaceuticals, Inc. 抗c-met串联fc双特异性抗体
EP3423572B1 (en) * 2016-03-02 2023-11-29 Momenta Pharmaceuticals, Inc. Methods related to engineered fc constructs
DK3484514T3 (da) * 2016-05-23 2024-01-29 Momenta Pharmaceuticals Inc Compositions and methods related to engineered fc constructs
WO2018129397A1 (en) * 2017-01-06 2018-07-12 Momenta Pharmaceuticals, Inc. Compositions and methods related to engineered fc-antigen binding domain constructs

Similar Documents

Publication Publication Date Title
JP2022551969A5 (https=)
CN107922486B (zh) 异源二聚体多特异性抗体形式
CN102448985B (zh) 三或四特异性抗体
JP2020531438A5 (ja) Nkg2d、cd16、およびhla−eに結合するタンパク質
JP2021094022A5 (https=)
JP2023538945A5 (https=)
JP2021098732A5 (https=)
IL261674A (en) Protein-like binding proteins with a double variable region have a cross-linking region direction
JP2023545057A5 (https=)
JP2018537966A5 (https=)
JP2021533159A5 (https=)
JP2023548045A5 (https=)
JP2023134618A5 (https=)
JP2022545647A5 (https=)
JP2023511376A5 (https=)
FI3781200T3 (fi) Kelatoituneiden radionuklidien vasta-aineita
JP2024501539A5 (https=)
JP2022512234A5 (https=)
JP7657591B2 (ja) 二重特異性抗原結合コンストラクト
JP2025160226A5 (https=)
JP2023548529A5 (https=)
JP2024512386A5 (https=)
JP2021531268A5 (https=)
JP2023549555A5 (https=)
JP2025511391A5 (https=)